Wednesday COVID-19 Roundup: SCV Cases Total 27,612; Public Health Encourages Safety Measures,Vaccinations to Reduce Risk of Getting COVID-19
Uploaded: , Wednesday, Apr 21, 2021
By Press Release
The Los Angeles County Department of Public Health confirmed Wednesday 35 new deaths and 439 new cases of COVID-19, with 27,612 total cases in the Santa Clarita Valley.
To date, Public Health identified 1,229,998 positive cases of COVID-19 across all areas of L.A. County and a total of 23,702 deaths.
Of the 35 new deaths reported today, 13 people that passed away were over the age of 80, 11 people who died were between the ages of 65 and 79, nine people who died were between the ages of 50 and 64, and two people who died were between the ages of 30 and 49.
SCV News | Tuesday COVID-19 Roundup: L A County Remains in Orange Tier; SCV Cases Total 27,595
scvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scvnews.com Daily Mail and Mail on Sunday newspapers.
ixlayer Expands Partnership with On-Demand Logistics Service Senpex to Provide Same-Day Delivery of Lab Tests to Patients, Hospitals and Clinical Labs
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Digital Editor Once authorized, the rapid COVID-19 test can be fully performed using only a smartphone and a lateral flow assay (similar to an at-home pregnancy test).
Kroger Health, the health care division of The Kroger Co., has simplified the COVID-19 testing process to make it accessible by anyone with a smartphone. Its smartphone-enabled at-home Gauss COVID-19 Rapid Antigen Test Kit is currently awaiting Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
The affordable testing technology was developed by Gauss Surgical, a computer vision-focused health care company. Once authorized, it will be the first rapid COVID-19 test that can be fully performed using only a smartphone and a lateral flow assay (similar to an at-home pregnancy test), without involving a laboratory, a telemedicine visit or any specialized electronics. Last month, Gauss produced its first 1.5 million tests, which will be available for immediate distribution when the te